Radiofrequency Ablation for Back Pain: 4 Sham Trials Split 2–2

Quick Answer: Radiofrequency ablation (also called radiofrequency denervation or neurotomy) heats the small medial branch nerves that carry pain from the facet joints of the spine. For low back pain, the evidence splits. The four sham-controlled trials of lumbar facet ablation we read divided 2–2: two found a benefit over a fake procedure, two did not on their main measures. The largest trial, MINT (681 patients in the Netherlands, JAMA 2017), found ablation added to an exercise programme lowered pain by only 0.18 points out of 10 for facet joint pain, against a 2-point threshold for a difference patients notice. Cochrane’s 2015 review of 23 trials found “no high-quality evidence” of pain relief. The trials that did find large effects had one thing in common: they selected patients more strictly before treating them. That matters because a single numbing test block, the usual way to pick candidates, was falsely positive 38% of the time in a 176-patient study. When it does work, relief in the clinic series lasted a mean of 10.5 months in the lower back and 12.5 months in the neck, and repeat treatments worked about as often as the first.

This page explains what the procedure is, what each kind of trial found, why the results disagree, how long relief lasts, and what to ask before agreeing to it. It is about facet joint pain in the lower back and neck. It does not cover radiofrequency for the sacroiliac joint, the discs or the knee, which have separate evidence. We do not link to any product on this page.

Radiofrequency ablation for back pain: the evidence at a glance

What the procedure actually does

Each facet joint, the small paired joints at the back of each spinal level, is supplied by two tiny nerves called medial branches. Radiofrequency ablation places an insulated needle electrode next to those nerves under X-ray guidance and heats the tip. The 2020 multisociety guideline on lumbar facet procedures, written by a committee convened by the American Society of Regional Anesthesia and Pain Medicine, recommends fluoroscopy for the procedure and lists a tip temperature of 80°C to 90°C for conventional ablation. The heat coagulates a short length of nerve, so pain signals from the joint stop until the nerve grows back.

That last point explains two features of the treatment. First, it is not permanent: the nerve regenerates, so the effect is measured in months. Second, it only helps pain that is actually coming from the facet joints. Heating the medial branches does nothing for pain from a disc, a nerve root, the sacroiliac joint or muscle. Choosing who to treat is therefore the whole game, and it is where the evidence gets complicated.

Conventional versus pulsed radiofrequency

Pulsed radiofrequency delivers the current in short bursts so the tissue does not reach the temperature that destroys the nerve. It is used where destroying a nerve is undesirable. For facet joints, a 2007 trial of 60 people compared conventional ablation at 80°C, pulsed radiofrequency at 2 Hz and a local anaesthetic control. Both active methods beat the control at first, but “this decrease discontinued in the PRF group” at 6 months and 1 year, while the conventional group kept its improvement. The authors concluded that pulsed treatment “is not as long lasting” as conventional ablation for facet pain.

Why the trials disagree: the test block decides

Before ablation, patients normally receive a diagnostic block: a small amount of local anaesthetic placed on the medial branches. If the pain eases for the hours the anaesthetic lasts, the facet joints are presumed to be the source, and ablation is offered.

The problem is that people often feel better after any injection. In a 1994 study in the journal Pain, 176 consecutive patients with chronic low back pain received a first block with lidocaine. Eighty-three (47%) reported definite relief. When those who responded were given a confirmatory block with a longer-acting anaesthetic, only 26 (15%) responded again. Using the confirmatory block as the reference, the authors calculated that single uncontrolled blocks had a false-positive rate of 38% and a positive predictive value of only 31%. In their words, single blocks “will always be associated with an unacceptably low positive predictive value.”

Read the trials with that in mind:

• The two clearly positive studies selected strictly. Nath 2008 required three separate positive blocks before anyone was randomised. Lord 1996, in the neck, confirmed the pain source with double-blind, placebo-controlled anaesthetic blocks.
• The negative or flat studies used looser selection. Leclaire 2001 chose patients by their response to injections into the joint itself, which the 2020 guideline rates as having “poorer predictive value before RFA” than medial branch blocks. van Wijk 2005 used one block with at least 50% relief. MINT used a positive diagnostic block and was designed to reflect everyday Dutch practice.
• van Kleef 1999 sits in between: single blocks, and a positive result that reached significance only after statistical adjustment.

The uncontrolled results look strongest of all when selection is strictest. In a 2000 audit of 15 people chosen with controlled diagnostic blocks, 60% had at least 90% relief at 12 months and 87% had at least 60% relief. That study had no comparison group, so it shows what is possible in carefully chosen patients rather than how much of the improvement is due to the heat.

The guideline chose the looser test anyway

This is the part most explanations leave out. The 2020 multisociety guideline, the main professional document supporting the procedure, recommends a single block before ablation, with more than 50% relief as the threshold. It acknowledges that “using multiple blocks may improve RFA success rates,” but chooses one block because stricter testing “will also result in patients who might benefit from RFA being denied treatment.” The committee rated that recommendation grade C, low-to-moderate certainty, and one participating society dissented on exactly these two questions, the number of blocks and the cut-off.

So the standard pathway knowingly accepts more false positives, meaning more people treated whose pain may not come from the facet joints, in exchange for missing fewer who would benefit. That is a defensible trade-off, but it is also a reason why results in routine practice may sit closer to MINT than to Nath.

MINT: the largest trial, and the one that found nothing useful

The Mint study, published in JAMA in 2017, ran three pragmatic trials at 16 pain clinics in the Netherlands. Everyone received a 3-month standardised exercise programme, with psychological support if needed; half also received radiofrequency denervation, up to three times. The primary outcome was pain on a 0–10 scale at 3 months, and the researchers set 2 points as the smallest difference that would matter to patients.

• Facet joint trial, 251 people: difference −0.18 points (95% CI −0.76 to 0.40).
• Sacroiliac joint trial, 228 people: −0.71 points.
• Combination trial (facet, sacroiliac or disc), 202 people: −0.99 points.

The authors concluded that “the findings do not support the use of radiofrequency denervation to treat chronic low back pain from these sources.” MINT was not blinded and compared against exercise rather than a sham, so it measures what ablation adds in real-world care rather than whether the heat has any biological effect. PubMed links seven published letters and commentaries to it, including a response in the guideline’s own journal, which gives a sense of how contested it was.

What Cochrane concluded

The 2015 Cochrane review pooled 23 randomised trials with 1,309 people. For facet joint pain, it found “moderate evidence” that ablation reduces pain more than placebo in the short term, by 1.47 points on a 0–10 scale, and low-quality evidence for small gains in function. Ablation also beat steroid injections, on evidence the review rated very low to low quality. For disc pain the results conflicted, and for sacroiliac joint pain there was no short-term difference from placebo.

The review’s conclusion was blunt: “The review authors found no high-quality evidence suggesting that RF denervation provides pain relief for patients with CLBP.” It also noted that “The quality and size of original studies were inadequate to permit assessment of how often complications occur.” One of its authors leads a rehabilitation unit where radiofrequency is used, which the review disclosed.

Neck pain: the strongest single trial

The best-known trial in this field is in the neck, not the lower back. In 1996 the New England Journal of Medicine published a double-blind trial of 24 people with neck pain from the facet joints after a car accident, all with the source confirmed by placebo-controlled blocks. Twelve received ablation at 80°C with multiple lesions and twelve an identical procedure with the current switched off.

• Median time before pain returned to at least half its previous level: 263 days with ablation, 8 days with sham (P = 0.04).
• At 27 weeks, seven people in the ablation group and one in the sham group were free of pain.
• Five people in the ablation group had numbness in the area of the treated nerves, “but none considered it troubling.”

It is a small trial in a specific group, whiplash with rigorously confirmed facet pain, so it supports the procedure for that group rather than for neck pain in general.

How long relief lasts, and whether repeating it works

Because the nerve grows back, the useful question is not whether pain returns but when, and whether a second treatment works as well.

Both are retrospective reviews of patients whose first treatment had already worked, so they describe what happens to responders, not to everyone who is treated. The 2020 guideline recommends repeating ablation in people who obtained “at least 3 (and preferably 6) months of relief, up to two times per year,” and states that success “decreases for successive procedures but remains above 50%” (grade B, moderate certainty). It does not recommend repeating the diagnostic blocks before each repeat treatment if the original pain returns in the expected timeframe.

Risks the guideline lists

The guideline’s summary table names the complications and how to reduce them:

• Nerve irritation (neuritis): a steroid injection after ablation “may prevent neuritis” (grade C).
• Nerve root injury: reduced by confirming electrode position in multiple X-ray views and testing with stimulation.
• Muscle changes: ablation “can result in paraspinal muscle degeneration and possibly disc degeneration, though the clinical relevance of this is unclear.” The guideline recommends discussing this with patients and considering physical therapy before and after.
• Implanted devices: radiofrequency current can interfere with pacemakers and neurostimulators, so the device team should be consulted first.
• Burns: from equipment faults or poor grounding pad placement, rated grade B.
• Blood thinners: the guideline recommends continuing anticoagulants for facet procedures, with individual cases discussed with the prescribing team.

Numbness over the treated area is common and was reported in five of the twelve treated patients in the neck trial. Previous spine surgery is associated with lower success rates.

Questions to ask before agreeing to it

• How was my facet joint pain confirmed? One block or two, medial branch block or joint injection, and how much relief did I report? The guideline’s own threshold is more than 50%, and it notes that higher thresholds may give better results.
• Was sedation used for the test block? The guideline says sedation “should not be routinely used” because it can distort the response.
• Have I tried conservative care? The guideline recommends a 3-month trial of different conservative treatments before facet procedures.
• Conventional or pulsed? For facet joints, conventional heating lasted longer in the comparison trial.
• What happens when it wears off? Ask about repeat treatment and the plan for exercise alongside it, since MINT showed exercise does much of the work.

These are questions for a spine or pain specialist who can examine you and review your imaging. Whether ablation is reasonable depends on where your pain is coming from, which no general article can decide.

Frequently Asked Questions

Does radiofrequency ablation work for back pain?

For pain confirmed to come from the facet joints, it can, but the evidence is mixed. Cochrane found a short-term benefit over placebo of about 1.5 points out of 10 and “no high-quality evidence” of relief overall, and the 681-patient MINT trial found no clinically important benefit when added to exercise. Trials that selected patients with multiple or placebo-controlled blocks found much larger effects.

How long does radiofrequency ablation last?

In clinic series of people whose first treatment worked, relief lasted a mean of 10.5 months in the lower back and 12.5 months in the neck. In the 1996 neck trial, the median was 263 days before pain returned to half its earlier level.

Can radiofrequency ablation be repeated?

Yes. In two retrospective series, 85% of second lower back treatments and 95% of repeat neck treatments were successful. The 2020 guideline recommends repeating it for people who had at least 3, and preferably 6, months of relief, up to twice a year.

What is the success rate of the diagnostic block?

In a study of 176 patients, 47% responded to a first block but only 15% to a confirmatory block, giving single blocks a false-positive rate of 38%. That is why some specialists use two blocks, although the 2020 guideline recommends one.

What is the difference between pulsed and conventional radiofrequency?

Conventional ablation heats the nerve to about 80°C to 90°C and destroys a short section of it. Pulsed radiofrequency uses bursts that keep the temperature lower. For facet joint pain, a 60-person trial found the pulsed effect faded by 6 months while the conventional effect lasted a year.

What are the side effects of radiofrequency ablation?

Numbness or irritation over the treated nerves, temporary soreness, rare nerve root injury, burns from equipment problems, interference with implanted devices, and possible changes in the back muscles. Cochrane noted that trials were too small to say how often complications occur.

The Bottom Line

Radiofrequency ablation for back pain is a procedure whose results depend on who receives it. In trials that confirmed the pain source strictly, it produced long, sometimes dramatic relief; in larger and looser trials, it added little to exercise. The standard pathway uses a single test block, which in one study was wrong 38% of the time, and the main guideline chose that deliberately. If ablation is offered, the most useful thing to understand is how your facet joint pain was confirmed.

Sources

1. Maas ET, Ostelo RW, Niemisto L, et al. Radiofrequency denervation for chronic low back pain. Cochrane Database Syst Rev. 2015;(10):CD008572. PubMed 26495910. 23 RCTs, 1,309 participants; facet joint RF vs placebo short-term pain MD −1.47 (95% CI −2.28 to −0.67); “no high-quality evidence”; complication rates not assessable. Checked 29 October 2026.
2. Juch JNS, Maas ET, Ostelo RWJG, et al. Effect of radiofrequency denervation on pain intensity among patients with chronic low back pain: the Mint randomized clinical trials. JAMA. 2017;318(1):68-81. PubMed 28672319. 681 participants, 16 clinics; facet trial 251, sacroiliac 228, combination 202; differences −0.18, −0.71 and −0.99 against a 2-point threshold. Checked 29 October 2026.
3. Cohen SP, Bhaskar A, Bhatia A, et al. Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group. Reg Anesth Pain Med. 2020;45(6):424-467. PubMed 32245841; full text PMC7362874. Single block, >50% threshold, repeat RFA up to twice a year, 80°C–90°C, complications table. Checked 29 October 2026.
4. Schwarzer AC, Aprill CN, Derby R, et al. The false-positive rate of uncontrolled diagnostic blocks of the lumbar zygapophysial joints. Pain. 1994;58(2):195-200. PubMed 7816487. 176 patients; 83 (47%) responded to the first block, 26 (15%) to the confirmatory block; false-positive rate 38%, positive predictive value 31%. Checked 29 October 2026.
5. van Kleef M, Barendse GA, Kessels A, et al. Randomized trial of radiofrequency lumbar facet denervation for chronic low back pain. Spine. 1999;24(18):1937-42. PubMed 10515020. 31 patients; 10 of 15 vs 6 of 16 successes; unadjusted odds ratio 3.3 (P = 0.05), adjusted 4.8. Checked 29 October 2026.
6. Leclaire R, Fortin L, Lambert R, et al. Radiofrequency facet joint denervation in the treatment of low back pain: a placebo-controlled clinical trial to assess efficacy. Spine. 2001;26(13):1411-6. PubMed 11458140. 70 patients selected by intra-articular injection; Roland-Morris 8.4% vs 2.2% at 4 weeks; no effect at 12 weeks. Checked 29 October 2026.
7. van Wijk RM, Geurts JW, Wynne HJ, et al. Radiofrequency denervation of lumbar facet joints in the treatment of chronic low back pain: a randomized, double-blind, sham lesion-controlled trial. Clin J Pain. 2005;21(4):335-44. PubMed 15951652. 81 of 462 randomised; success 27.5% vs 29.3% (P = 0.86). Checked 29 October 2026.
8. Nath S, Nath CA, Pettersson K. Percutaneous lumbar zygapophysial (facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain: a randomized double-blind trial. Spine. 2008;33(12):1291-7. PubMed 18496338. 40 patients, 3 separate positive blocks. Checked 29 October 2026.
9. Lord SM, Barnsley L, Wallis BJ, et al. Percutaneous radio-frequency neurotomy for chronic cervical zygapophyseal-joint pain. N Engl J Med. 1996;335(23):1721-6. PubMed 8929263. 24 patients; median 263 vs 8 days (P = 0.04); 7 vs 1 pain-free at 27 weeks; numbness in 5. Checked 29 October 2026.
10. Dreyfuss P, Halbrook B, Pauza K, et al. Efficacy and validity of radiofrequency neurotomy for chronic lumbar zygapophysial joint pain. Spine. 2000;25(10):1270-7. PubMed 10806505. 15 patients; 60% at least 90% relief and 87% at least 60% relief at 12 months; no control group. Checked 29 October 2026.
11. Tekin I, Mirzai H, Ok G, et al. A comparison of conventional and pulsed radiofrequency denervation in the treatment of chronic facet joint pain. Clin J Pain. 2007;23(6):524-9. PubMed 17575493. 60 patients, 20 per group; pulsed effect discontinued at 6 months and 1 year. Checked 29 October 2026.
12. Schofferman J, Kine G. Effectiveness of repeated radiofrequency neurotomy for lumbar facet pain. Spine. 2004;29(21):2471-3. PubMed 15507813. 20 patients; first treatment mean 10.5 months; second successful in 17 (85%), mean 11.6 months. Checked 29 October 2026.
13. Husted DS, Orton D, Schofferman J, Kine G. Effectiveness of repeated radiofrequency neurotomy for cervical facet joint pain. J Spinal Disord Tech. 2008;21(6):406-8. PubMed 18679094. 22 patients; first treatment mean 12.5 months; 39 of 41 repeat treatments successful (95%). Checked 29 October 2026.